Marco A. Gamba-Alcocer

Santiago De Queretaro, QUE, MX 
Santiago De Queretaro, QUE, MX 

Overview

Marco Gamba-Alcocer practices practicing medicine in Santiago De Queretaro, Mexico.

His clinical expertise encompasses Pneumonia, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Severe Acute Respiratory Syndrome (SARS), and Percutaneous Coronary Intervention (PCI).

He is actively involved in clinical research, co-authoring 37 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Santiago De Queretaro, QUE, Mexico
Other Locations
Tlazala De Fabela, MEX, Mexico
Mexico, MEX, Mexico
La Ciudad, DUR, Mexico

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
Enrollment Status: Completed
Publish Date: August 20, 2025
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
View 1 Less Clinical Trial

37 Total Publications

Barriers to cardiac device access in heart failure patients: a multicenter study in Mexico.
Barriers to cardiac device access in heart failure patients: a multicenter study in Mexico.
Journal: Archivos de cardiologia de Mexico
Published: April 06, 2026

Frequently Asked Questions about Marco A. Gamba-Alcocer

Is Marco A. Gamba-Alcocer a top-rated expert for Pneumonia?

MediFind is an objective health platform that identifies experts based on real-world data. Marco A. Gamba-Alcocer is classified as an Experienced expert for Pneumonia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Marco A. Gamba-Alcocer participate in research or clinical trials?

Yes. Marco A. Gamba-Alcocer has published 37 articles and abstracts on conditions like Pneumonia. You can view a list of Marco A. Gamba-Alcocer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gamba-Alcocer's expertise for a condition
ConditionClose
        View All 13 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile